Literature DB >> 24865699

Image quality and cancer visibility of T2-weighted magnetic resonance imaging of the prostate at 7 Tesla.

E K Vos1, M W Lagemaat, J O Barentsz, J J Fütterer, P Zámecnik, H Roozen, S Orzada, A K Bitz, M C Maas, T W J Scheenen.   

Abstract

OBJECTIVES: To assess the image quality of T2-weighted (T2w) magnetic resonance imaging of the prostate and the visibility of prostate cancer at 7 Tesla (T). MATERIALS &
METHODS: Seventeen prostate cancer patients underwent T2w imaging at 7T with only an external transmit/receive array coil. Three radiologists independently scored images for image quality, visibility of anatomical structures, and presence of artefacts. Krippendorff's alpha and weighted kappa statistics were used to assess inter-observer agreement. Visibility of prostate cancer lesions was assessed by directly linking the T2w images to the confirmed location of prostate cancer on histopathology.
RESULTS: T2w imaging at 7T was achievable with 'satisfactory' (3/5) to 'good' (4/5) quality. Visibility of anatomical structures was predominantly scored as 'satisfactory' (3/5) and 'good' (4/5). If artefacts were present, they were mostly motion artefacts and, to a lesser extent, aliasing artefacts and noise. Krippendorff's analysis revealed an α = 0.44 between three readers for the overall image quality scores. Clinically significant cancer lesions in both peripheral zone and transition zone were visible at 7T.
CONCLUSION: T2w imaging with satisfactory to good quality can be routinely acquired, and cancer lesions were visible in patients with prostate cancer at 7T using only an external transmit/receive body array coil. KEY POINTS: • Satisfactory to good T2-weighted image quality of the prostate is achievable at 7T. • Periprostatic lipids appear hypo-intense compared to healthy peripheral zone tissue at 7T. • Prostate cancer is visible on T2-weighted MRI at 7T.

Entities:  

Mesh:

Year:  2014        PMID: 24865699     DOI: 10.1007/s00330-014-3234-6

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  20 in total

Review 1.  Prostate cancer: multiparametric MR imaging for detection, localization, and staging.

Authors:  Caroline M A Hoeks; Jelle O Barentsz; Thomas Hambrock; Derya Yakar; Diederik M Somford; Stijn W T P J Heijmink; Tom W J Scheenen; Pieter C Vos; Henkjan Huisman; Inge M van Oort; J Alfred Witjes; Arend Heerschap; Jurgen J Fütterer
Journal:  Radiology       Date:  2011-10       Impact factor: 11.105

2.  Evaluation of the ESUR PI-RADS scoring system for multiparametric MRI of the prostate with targeted MR/TRUS fusion-guided biopsy at 3.0 Tesla.

Authors:  M C Roethke; T H Kuru; S Schultze; D Tichy; A Kopp-Schneider; M Fenchel; H-P Schlemmer; B A Hadaschik
Journal:  Eur Radiol       Date:  2013-10-03       Impact factor: 5.315

3.  Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.

Authors:  Hebert Alberto Vargas; Oguz Akin; Amita Shukla-Dave; Jingbo Zhang; Kristen L Zakian; Junting Zheng; Kent Kanao; Debra A Goldman; Chaya S Moskowitz; Victor E Reuter; James A Eastham; Peter T Scardino; Hedvig Hricak
Journal:  Radiology       Date:  2012-09-05       Impact factor: 11.105

4.  Phosphorus magnetic resonance spectroscopic imaging at 7 T in patients with prostate cancer.

Authors:  Miriam W Lagemaat; Eline K Vos; Marnix C Maas; Andreas K Bitz; Stephan Orzada; Mark J van Uden; Thiele Kobus; Arend Heerschap; Tom W J Scheenen
Journal:  Invest Radiol       Date:  2014-05       Impact factor: 6.016

5.  Feasibility of T2 -weighted turbo spin echo imaging of the human prostate at 7 tesla.

Authors:  Marnix C Maas; Eline K Vos; Miriam W Lagemaat; Andreas K Bitz; Stephan Orzada; Thiele Kobus; Oliver Kraff; Stefan Maderwald; Mark E Ladd; Tom W J Scheenen
Journal:  Magn Reson Med       Date:  2013-06-24       Impact factor: 4.668

6.  Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study.

Authors:  Flavie Bratan; Emilie Niaf; Christelle Melodelima; Anne Laure Chesnais; Rémi Souchon; Florence Mège-Lechevallier; Marc Colombel; Olivier Rouvière
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

Review 7.  Role of high-field MR in studies of localized prostate cancer.

Authors:  Miriam W Lagemaat; Tom W J Scheenen
Journal:  NMR Biomed       Date:  2013-05-24       Impact factor: 4.044

8.  Multiparametric MRI for prostate cancer localization in correlation to whole-mount histopathology.

Authors:  Sofie Isebaert; Laura Van den Bergh; Karin Haustermans; Steven Joniau; Evelyne Lerut; Liesbeth De Wever; Frederik De Keyzer; Tom Budiharto; Pieter Slagmolen; Hendrik Van Poppel; Raymond Oyen
Journal:  J Magn Reson Imaging       Date:  2012-11-21       Impact factor: 4.813

9.  In vivo 31P MR spectroscopic imaging of the human prostate at 7 T: safety and feasibility.

Authors:  Thiele Kobus; Andreas K Bitz; Mark J van Uden; Miriam W Lagemaat; Eva Rothgang; Stephan Orzada; Arend Heerschap; Tom W J Scheenen
Journal:  Magn Reson Med       Date:  2012-02-24       Impact factor: 4.668

10.  ESUR prostate MR guidelines 2012.

Authors:  Jelle O Barentsz; Jonathan Richenberg; Richard Clements; Peter Choyke; Sadhna Verma; Geert Villeirs; Olivier Rouviere; Vibeke Logager; Jurgen J Fütterer
Journal:  Eur Radiol       Date:  2012-02-10       Impact factor: 5.315

View more
  9 in total

Review 1.  Progress in Imaging the Human Torso at the Ultrahigh Fields of 7 and 10.5 T.

Authors:  Kamil Uğurbil; Pierre-Francois Van de Moortele; Andrea Grant; Edward J Auerbach; Arcan Ertürk; Russell Lagore; Jutta M Ellermann; Xiaoxuan He; Gregor Adriany; Gregory J Metzger
Journal:  Magn Reson Imaging Clin N Am       Date:  2021-02       Impact factor: 2.266

Review 2.  Ultra-high-field MR in Prostate cancer: Feasibility and Potential.

Authors:  Carlijn J A Tenbergen; Gregory J Metzger; Tom W J Scheenen
Journal:  MAGMA       Date:  2022-05-17       Impact factor: 2.533

Review 3.  Novel methods for mapping the cavernous nerves during radical prostatectomy.

Authors:  Nathaniel M Fried; Arthur L Burnett
Journal:  Nat Rev Urol       Date:  2015-08       Impact factor: 14.432

4.  1.5 versus 3 versus 7 Tesla in abdominal MRI: A comparative study.

Authors:  Anja Laader; Karsten Beiderwellen; Oliver Kraff; Stefan Maderwald; Karsten Wrede; Mark E Ladd; Thomas C Lauenstein; Michael Forsting; Harald H Quick; Kai Nassenstein; Lale Umutlu
Journal:  PLoS One       Date:  2017-11-10       Impact factor: 3.240

5.  Design of a forward view antenna for prostate imaging at 7 T.

Authors:  Bart R Steensma; Ingmar Voogt; Abe J van der Werf; Cornelis A T van den Berg; Peter R Luijten; Dennis W J Klomp; Alexander J E Raaijmakers
Journal:  NMR Biomed       Date:  2018-07-18       Impact factor: 4.044

Review 6.  Evolution of UHF Body Imaging in the Human Torso at 7T: Technology, Applications, and Future Directions.

Authors:  M Arcan Erturk; Xiufeng Li; Pierre-Fancois Van de Moortele; Kamil Ugurbil; Gregory J Metzger
Journal:  Top Magn Reson Imaging       Date:  2019-06

7.  A 32-channel parallel transmit system add-on for 7T MRI.

Authors:  Stephan Orzada; Klaus Solbach; Marcel Gratz; Sascha Brunheim; Thomas M Fiedler; Sören Johst; Andreas K Bitz; Samaneh Shooshtary; Ashraf Abuelhaija; Maximilian N Voelker; Stefan H G Rietsch; Oliver Kraff; Stefan Maderwald; Martina Flöser; Mark Oehmigen; Harald H Quick; Mark E Ladd
Journal:  PLoS One       Date:  2019-09-12       Impact factor: 3.240

Review 8.  Focal therapy for prostate cancer: what is really needed to move from investigational to valid therapeutic alternative?-a narrative review.

Authors:  Antony Pellegrino; Giuseppe O Cirulli; Elio Mazzone; Francesco Barletta; Simone Scuderi; Mario de Angelis; Giuseppe Rosiello; Giorgio Gandaglia; Francesco Montorsi; Alberto Briganti; Armando Stabile
Journal:  Ann Transl Med       Date:  2022-07

9.  Comparing signal-to-noise ratio for prostate imaging at 7T and 3T.

Authors:  Bart R Steensma; Mariska Luttje; Ingmar J Voogt; Dennis W J Klomp; Peter R Luijten; Cornelis A T van den Berg; Alexander J E Raaijmakers
Journal:  J Magn Reson Imaging       Date:  2018-10-22       Impact factor: 4.813

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.